Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects
Clinical trial NCT04439578 · COMPLETED
Trial details
- NCT number
- NCT04439578
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2020-08-17
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.